Grant Wickman

Nonclinical Antiangiogenesis and Antitumor Activities of Axitinib (AG-013736), an Oral, Potent, and Selective Inhibitor of Vascular Endothelial Growth Factor Receptor Tyrosine Kinases 1, 2, 3

Dana D. Hu‐Lowe, Helen Y. Zou, Maren L. Grazzini et al. · Clinical Cancer Research · 2008 · 628 citations

Medicine, Oncology, Pharmacology +17

Blebs produced by actin–myosin contraction during apoptosis release damage-associated molecular pattern proteins before secondary necrosis occurs

Grant Wickman, Linda Julian, Katerina Mardilovich et al. · Cell Death and Differentiation · 2013 · 194 citations · Full text

Life Sciences, Cell Biology, Molecular Biology +17

LIM kinases are required for invasive path generation by tumor and tumor-associated stromal cells

Rebecca W. Scott, Steven Hooper, Diane Crighton et al. · The Journal of Cell Biology · 2010 · 176 citations · Full text

Life Sciences, Cell Biology, Molecular Biology +17

An anti-HER2 biparatopic antibody that induces unique HER2 clustering and complement-dependent cytotoxicity

Nina E. Weisser, Mário Sanches, Eric Escobar-Cabrera et al. · Nature Communications · 2023 · 163 citations · Full text

Medicine, Medicinal Chemistry, Oncology +17

Targeting Activin Receptor-Like Kinase 1 Inhibits Angiogenesis and Tumorigenesis through a Mechanism of Action Complementary to Anti-VEGF Therapies

Dana D. Hu‐Lowe, Enhong Chen, Lianglin Zhang et al. · Cancer Research · 2011 · 133 citations · Full text

Medicine, Oncology, Pharmacology +17